These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23531704)

  • 1. A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes.
    Lund IO; Fischer G; Welle-Strand GK; O'Grady KE; Debelak K; Morrone WR; Jones HE
    Subst Abuse; 2013; 7():61-74. PubMed ID: 23531704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
    Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder.
    Kanervo MM; Tupola SJ; Nikkola EM; Rantakari KM; Kahila HK
    Acta Obstet Gynecol Scand; 2023 Mar; 102(3):313-322. PubMed ID: 36562462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan.
    Goshgarian G; Jawad R; O'Brien L; Muterspaugh R; Zikos D; Ezhuthachan S; Newman C; Hsu CD; Bailey B; Ragina N
    Cureus; 2022 Aug; 14(8):e27790. PubMed ID: 36106254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine-naloxone use in pregnancy: a systematic review and metaanalysis.
    Link HM; Jones H; Miller L; Kaltenbach K; Seligman N
    Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100179. PubMed ID: 33345863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid dependence and pregnancy: minimizing stress on the fetal brain.
    McCarthy JJ; Leamon MH; Finnegan LP; Fassbender C
    Am J Obstet Gynecol; 2017 Mar; 216(3):226-231. PubMed ID: 27729254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
    Debelak K; Morrone WR; O'Grady KE; Jones HE
    Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing methadone and buprenorphine maintenance with methadone-assisted withdrawal for the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes.
    Lund IO; Fitzsimons H; Tuten M; Chisolm MS; O'Grady KE; Jones HE
    Subst Abuse Rehabil; 2012; 3(Suppl 1):17-25. PubMed ID: 24474873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine and naloxone compared with methadone treatment in pregnancy.
    Wiegand SL; Stringer EM; Stuebe AM; Jones H; Seashore C; Thorp J
    Obstet Gynecol; 2015 Feb; 125(2):363-368. PubMed ID: 25569005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of naltrexone in treating opioid use disorder in pregnancy.
    Towers CV; Katz E; Weitz B; Visconti K
    Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery dose of methadone, but not buprenorphine, is associated with the risk and severity of neonatal opiate withdrawal syndrome.
    Lappen JR; Stark S; Bailit JL; Gibson KS
    Am J Obstet Gynecol MFM; 2020 Feb; 2(1):100075. PubMed ID: 33345989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone.
    Gawronski KM; Prasad MR; Backes CR; Lehman KJ; Gardner DK; Cordero L
    SAGE Open Med; 2014; 2():2050312114530282. PubMed ID: 26770721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Buprenorphine-Naloxone in Pregnancy: A Systematic Review of the Literature.
    Ordean A; Tubman-Broeren M
    Pathophysiology; 2023 Feb; 30(1):27-36. PubMed ID: 36810423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
    Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
    Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Swedish Population-based Study of Adverse Birth Outcomes among Pregnant Women Treated with Buprenorphine or Methadone: Preliminary Findings.
    Wurst KE; Zedler BK; Joyce AR; Sasinowski M; Murrelle EL
    Subst Abuse; 2016; 10():89-97. PubMed ID: 27679504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal abstinence syndrome after methadone or buprenorphine exposure.
    Jones HE; Kaltenbach K; Heil SH; Stine SM; Coyle MG; Arria AM; O'Grady KE; Selby P; Martin PR; Fischer G
    N Engl J Med; 2010 Dec; 363(24):2320-31. PubMed ID: 21142534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone and buprenorphine for the management of opioid dependence in pregnancy.
    Jones HE; Finnegan LP; Kaltenbach K
    Drugs; 2012 Apr; 72(6):747-57. PubMed ID: 22512363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder.
    Thakrar AP; Uritsky TJ; Christopher C; Winston A; Ronning K; Sigueza AL; Caputo A; McFadden R; Olenik JM; Perrone J; Delgado MK; Lowenstein M; Compton P
    Addict Sci Clin Pract; 2023 Feb; 18(1):13. PubMed ID: 36829242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance agonist treatments for opiate-dependent pregnant women.
    Minozzi S; Amato L; Bellisario C; Ferri M; Davoli M
    Cochrane Database Syst Rev; 2013 Dec; (12):CD006318. PubMed ID: 24366859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.